-
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
17 Sep 2025 11:00 GMT
… safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1 … (clesrovimab). Tonix Pharmaceuticals Holding Corp.* Tonix Pharmaceuticals is a fully- … , Md. * Tonix’s product development candidates are investigational new drugs …
-
SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics
16 Sep 2025 12:41 GMT
… -- SERB Pharmaceuticals (“SERB”), a global specialty pharmaceutical company focused on … the costly and time-consuming pharmaceutical product development process and the uncertainty of … , Corporate Communications Director
SERB Pharmaceuticals
+44 7773 251 178
…
-
FDA Grants Fast Track Designation to Corbus Pharmaceuticals’ Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma
16 Sep 2025 12:00 GMT
… , 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“ … Company's trial results, product development, clinical and regulatory timelines, market … Moran
Chief Financial Officer
Corbus Pharmaceuticals
smoran@corbuspharma.com Dan …
-
Jamjoom Pharma enters deal with Bio-Thera for Cosentyx biosimilar
16 Sep 2025 11:47 GMT
… Pharmaceuticals Factory Company (Jamjoom Pharma), one of the fastest-growing pharmaceutical companies … .
Cosentyx is a biologic medication used to treat conditions like … while Bio-Thera will oversee product development and global manufacturing from its …
-
Italfarmaco Announces Exclusive Distribution Agreement with Multicare Pharma for DMD Treatment Givinostat in Brazil
16 Sep 2025 09:00 GMT
… agreement with Multicare Pharma, a prominent pharmaceutical company in Latin … is a leader in pharmaceutical research, product development, production and commercialisation … About Multicare Pharma
Multicare Pharma is a leading pharmaceutical company with …
-
Jamjoom Pharma partners with Bio-Thera to secure Cosentyx biosimilar in MENA
16 Sep 2025 07:34 GMT
… a press release.
Jamjoom Pharma will handle regulatory submissions, … Bio-Thera will oversee product development and global manufacturing from … Hosni, CEO of Jamjoom Pharma, said: “By joining … : “Partnering with JamJoom Pharma to bring BAT2306 to patients …
-
Animal Disinfectants Market Trends and Analysis by Application, Vertical, Region, and Segment Forecast to 2029
18 Sep 2025 01:30 GMT
The Business Research Company’s Animal Disinfectants Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, September 18, 2025 /EINPresswire.com/ -- What Is The Estimated Industry Size Of …
-
aTyr Pharma Announces Topline Results from Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
15 Sep 2025 11:30 GMT
… 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“ … Chief Executive Officer of aTyr Pharma. “These consistent findings … organizations and our partner Kyorin Pharmaceutical, Ltd., who all … for our business and product development plans, as well as …
-
Advancing Generic Drug Development: Translating Science to Approval - 09/21/2021
17 Sep 2025 23:03 GMT
… Products (OLDP)
Office of Pharmaceutical Quality (OPQ) | CDER
… Assessment Perspectives
Physiological Based Pharmacokinetic Modeling and Simulation Absorption … Pharmacokinetic Modeling and Simulation to Support Generic Ophthalmic Drug Product Development …
-
Jamjoom Pharma Strikes Strategic Deal with Bio-Thera for securing Cosentyx® Biosimilar in MENA
15 Sep 2025 09:25 GMT
… Pharmaceuticals Factory Company (Jamjoom Pharma), one of the fastest-growing pharmaceutical … Africa (MENA) region. Jamjoom Pharma will manage regulatory submissions, market … while Bio-Thera will oversee product development and global manufacturing from its …
About
© 1995-2025